Metabolic surgery is an effective treatment option for obese patients with type 2 diabetes mellitus (T2DM). Frequent relapses and significantly decreased remission rates have been started after 10 and 15 years in surgically treated patients. Further concern should be warranted on predictors related to gastrointestinal hormones and metabolic profile of long-term remission and relapse of T2DM following metabolic surgery in obese patients.
第一作者单位：[1]Department of Endocrinology, China-Japan Friendship Hospital, Beijing, China
通讯作者：
推荐引用方式(GB/T 7714)：
Chen Xiaoping,Kong Xiaomu.Diabetes remission and relapse after metabolic surgery[J].JOURNAL of DIABETES INVESTIGATION.2018,9(6):1237-1238.doi:10.1111/jdi.12871.
APA：
Chen, Xiaoping&Kong, Xiaomu.(2018).Diabetes remission and relapse after metabolic surgery.JOURNAL of DIABETES INVESTIGATION,9,(6)
MLA：
Chen, Xiaoping,et al."Diabetes remission and relapse after metabolic surgery".JOURNAL of DIABETES INVESTIGATION 9..6(2018):1237-1238
